TrialThe Lancet. Global health2022

Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial.

Nginache Nampota-Nkomba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.